Life sciences briefing: Monday, Jan. 7, 2008
TODAY’S HEADLINES:
Surgical-device maker Aragon Surgical receives $25M (release)
Tacere Therapeutics strikes RNAi deal with Pfizer for up to $145M (release)
Benvenue Medical raises $15M for spine-repair devices (release)
Genome-association co. Genizon BioSciences draws C$31M (release)
Contract research organization Inclinix pulls in $10M (release)
EPocrates, healthcare IT developer, gets strategic investment… Continue Reading
Tacere Therapeutics sells equity stake to Oncolys BioPharma for hepatitis-drug development
Tacere Therapeutics, a San Jose, Calif., biotech developing new RNA-based drugs, struck a partnership with Tokyo’s Oncolys BioPharma to co-develop a treatment for hepatitis C. The companies didn’t disclose financial terms of the deal.
In exchange for an undisclosed equity investment in Tacere, Oncolys will hold… Continue Reading